Eton Pharmaceuticals Inc (ETON) — Cash Flow-to-Debt Ratio
Eton Pharmaceuticals Inc (ETON) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2026, meaning its operating cash flow of $7.25 Million could theoretically repay 0% of its total liabilities ($69.22 Million) in one year. See ETON free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eton Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Eton Pharmaceuticals Inc across 9 annual periods. For the full cash flow conversion analysis, see Eton Pharmaceuticals Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Eton Pharmaceuticals Inc (2017–2025)
Year-by-year debt coverage analysis for Eton Pharmaceuticals Inc. Check Eton Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $10.52 Million | $65.96 Million | ▲ +751.2% |
| 2024 | 0.02x | $969.00K | $51.70 Million | ▼ -95.5% |
| 2023 | 0.42x | $6.82 Million | $16.26 Million | ▲ +3.9% |
| 2022 | 0.40x | $4.82 Million | $11.95 Million | ▲ +184.0% |
| 2021 | -0.48x | $-4.72 Million | $9.84 Million | ▲ +77.1% |
| 2020 | -2.10x | $-22.35 Million | $10.66 Million | ▲ +24.1% |
| 2019 | -2.76x | $-18.03 Million | $6.52 Million | ▲ +31.3% |
| 2018 | -4.02x | $-8.14 Million | $2.02 Million | ▼ -12.0% |
| 2017 | -3.59x | $-4.72 Million | $1.31 Million | — |